Patents by Inventor Kurt MARSHALL

Kurt MARSHALL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TARGETING, EDITING, OR MODIFYING GENES
    Publication number: 20250388935
    Abstract: Provided herein are nucleic acids useful as guide nucleic acids (gNAs), e.g., guide ribonucleic acids (gRNAs), in a CRISPR system wherein the guide nucleic acids contain one or more modifications to one or more nucleotides, use of such guide nucleic acids in modifying cells, and other uses wherein CRISPR Cas proteins are utilized.
    Type: Application
    Filed: April 30, 2025
    Publication date: December 25, 2025
    Applicants: Artisan Development Labs, Inc., Celyntra Therapeutics SA
    Inventors: Andrea BARGHETTI, Roland BAUMGARTNER, Tanya WARNECKE, Kurt MARSHALL, John SCHIEL, Alyssa CARLSON
  • Compositions and methods for targeting, editing, or modifying genes
    Patent number: 12319932
    Abstract: Provided herein are nucleic acids useful as guide nucleic acids (gNAs), e.g., guide ribonucleic acids (gRNAs), in a CRISPR system wherein the guide nucleic acids contain one or more modifications to one or more nucleotides, use of such guide nucleic acids in modifying cells, and other uses wherein CRISPR Cas proteins are utilized.
    Type: Grant
    Filed: October 3, 2022
    Date of Patent: June 3, 2025
    Assignee: Celyntra Therapeutics SA
    Inventors: Andrea Barghetti, Roland Baumgartner, Tanya Warnecke, Kurt Marshall, John Schiel, Alyssa Carlson
  • Compositions and methods for targeting, editing, or modifying genes
    Patent number: 12270043
    Abstract: Provided herein are nucleic acids useful as guide nucleic acids (gNAs), e.g., guide ribonucleic acids (gRNAs), in a CRISPR system wherein the guide nucleic acids contain one or more modifications to one or more nucleotides, use of such guide nucleic acids in modifying cells, and other uses wherein CRISPR Cas proteins are utilized.
    Type: Grant
    Filed: March 23, 2023
    Date of Patent: April 8, 2025
    Assignee: Celyntra Therapeutics SA
    Inventors: Andrea Barghetti, Roland Baumgartner, Tanya Warnecke, Kurt Marshall, John Schiel, Alyssa Carlson
  • COMPOSITIONS AND METHODS FOR TARGETING, EDITING, OR MODIFYING GENES
    Publication number: 20230265461
    Abstract: Provided herein are nucleic acids useful as guide nucleic acids (gNAs), e.g., guide ribonucleic acids (gRNAs), in a CRISPR system wherein the guide nucleic acids contain one or more modifications to one or more nucleotides, use of such guide nucleic acids in modifying cells, and other uses wherein CRISPR Cas proteins are utilized.
    Type: Application
    Filed: March 23, 2023
    Publication date: August 24, 2023
    Inventors: Andrea BARGHETTI, Roland BAUMGARTNER, Tanya WARNECKE, Kurt MARSHALL, John SCHIEL, Alyssa Carlson
  • COMPOSITIONS AND METHODS FOR TARGETING, EDITING, OR MODIFYING GENES
    Publication number: 20230235362
    Abstract: Provided herein are nucleic acids useful as guide nucleic acids (gNAs), e.g., guide ribonucleic acids (gRNAs), in a CRISPR system wherein the guide nucleic acids contain one or more modifications to one or more nucleotides, use of such guide nucleic acids in modifying cells, and other uses wherein CRISPR Cas proteins are utilized.
    Type: Application
    Filed: October 3, 2022
    Publication date: July 27, 2023
    Inventors: Andrea BARGHETTI, Roland BAUMGARTNER, Tanya WARNECKE, Kurt MARSHALL, John SCHIEL, Alyssa Carlson